Edition:
India

Edwards Lifesciences Corp (EW.N)

EW.N on New York Stock Exchange

83.73USD
7 Dec 2016
Change (% chg)

$0.51 (+0.61%)
Prev Close
$83.22
Open
$82.99
Day's High
$83.75
Day's Low
$81.90
Volume
573,051
Avg. Vol
414,838
52-wk High
$121.75
52-wk Low
$72.20

EW.N

Chart for EW.N

About

Edwards Lifesciences Corporation is focused on technologies that treat structural heart disease and critically ill patients. The Company manufactures heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. It develops hemodynamic monitoring systems used to measure a... (more)

Overall

Beta: 0.61
Market Cap(Mil.): $17,793.60
Shares Outstanding(Mil.): 213.81
Dividend: --
Yield (%): --

Financials

Edwards Lifesciences to buy Israel's Valtech for up to $690 million

JERUSALEM Edwards Lifesciences Corp on Monday said it has agreed to buy Israel's Valtech Cardio for $340 million in stock and cash, with the potential for an additional $350 million in pre-specified milestone-driven payments over the next 10 years.

28 Nov 2016

UPDATE 1-Edwards Lifesciences to buy Israel's Valtech for up to $690 mln

JERUSALEM, Nov 28 Edwards Lifesciences Corp on Monday said it has agreed to buy Israel's Valtech Cardio for $340 million in stock and cash, with the potential for an additional $350 million in pre-specified milestone-driven payments over the next 10 years.

28 Nov 2016

Edwards Lifesciences to buy Israel's Valtech for up to $690 mln

JERUSALEM, Nov 28 Edwards Lifesciences Corp on Monday said it has agreed to buy Israel's Valtech Cardio for $340 million in stock and cash, with the potential for an additional $350 million in pre-specified milestone-driven payments over the next 10 years.

28 Nov 2016

BRIEF-Edwards enters into agreement to acquire Valtech Cardio

* Purchase price of Valtech is $340 million in stock and cash at closing,

28 Nov 2016

Earnings in focus as Apple weighs; Boeing lifts Dow

Quarterly results were the main driver for Wall Street on Wednesday as a decline in Apple shares weighed on the S&P 500 and Nasdaq, while the price-weighted Dow Industrials was buoyed by gains in Boeing. | Video

27 Oct 2016

Earnings in focus as Apple weighs; Boeing lifts Dow

Quarterly results were the main driver for Wall Street on Wednesday as a decline in Apple shares weighed on the S&P 500 and Nasdaq, while the price-weighted Dow Industrials was buoyed by gains in Boeing. | Video

27 Oct 2016

FDA widens use of Edwards' devices for heart valve replacement

The U.S. Food and Drug Administration has widened the use of Edwards Lifesciences Corp's heart valves to patients at intermediate risk of complications if they underwent open heart surgery.

19 Aug 2016

FDA widens use of Edwards' devices for heart valve replacement

Aug 18 The U.S. Food and Drug Administration has widened the use of Edwards Lifesciences Corp's heart valves to patients at intermediate risk of complications if they underwent open heart surgery.

19 Aug 2016

BRIEF-EDWARDS INTUITY Elite Rapid Deployment Valve receives FDA approval

* Edwards INTUITY Elite Rapid Deployment Valve receives FDA approval Source text for Eikon: Further company coverage:

15 Aug 2016

BRIEF-Stantec signs letter of intent to acquire NYC-based Edwards & Zuck

* Stantec signs letter of intent to acquire NYC-based Edwards & Zuck: 120-person premiere buildings engineering firm Source text for Eikon: Further company coverage:

12 Aug 2016

Earnings vs. Estimates